European Healthtech startup funding raised during 2017.
In 2017, 357 European Healthtech companies raised a combined €3.5B across 384 funding rounds. Switzerland led by capital raised, and Bpifrance was the most active investor. Data as of 21 Aug 2026.
25 exits · €474M disclosed.
| Zur Rose | IPO | Jan 2017 | €184M |
| Europa Apotheek | Acquisition | Feb 2017 | €126M |
| VisionSense | Acquisition | Oct 2017 | €68M |
| Crospon | Acquisition | May 2017 | €41M |
| iSalud | Acquisition | Sep 2017 | €30M |
| Vitalsana | Acquisition | Oct 2017 | €14M |
| €80M |
| Babylon | Other | Apr 2017 | €56M |
| Simba Sleep | Series B | Apr 2017 | €47M |
| Xeltis | Series C | Apr 2017 | €45M |
| Market Logic | Other | May 2017 | €45M |
| Breath Therapeutics | Series A | Mar 2017 | €44M |
| Nouscom | Series B | Nov 2017 | €42M |
| Impulse Dynamics | Other | May 2017 | €41M |
| Ada health | Series A | Oct 2017 | €40M |
| Nightstar | Series C | Jul 2017 | €39M |
| Vivet Therapeutics | Series A | May 2017 | €38M |
| StarLeaf | Other | May 2017 | €37M |
